Mortal hyperkalemia disturbances in rats are NO-system related. The life saving effect of pentadecapeptide BPC 157

Regulatory Peptides

Volumn 181, Issue 1, 2013, Pages 50-66

  Barisic, Ivan ^a   Balenovic, Diana ^a   Klicek, Robert ^a   Radic, Bozo ^a   Nikitovic, Bojana ^a   Drmic, Domagoj ^a   Udovicic, Mario ^a   Strinic, Dean ^a   Bardak, Darija ^a   Berkopic, Lidija ^a   Djuzel, Viktor ^a   Sever, Marko ^a   Cvjetko, Ivan ^a   Romic, Zeljko ^a   Sindic, Aleksandra ^a   Bencic, Martina Lovric ^a   Seiwerth, Sven ^a   Sikiric, Predrag ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Gastric lesions; Hyperkalemia; L Arginine; L NAME; Lethality; Pentadecapeptide BPC 157

Indexed keywords

ARGININE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; N(G) NITROARGININE METHYL ESTER; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; HEART ARRHYTHMIA; HUMAN; HUMAN CELL; HYPERKALEMIA; HYPERTENSION; MALE; MEMBRANE POTENTIAL; MUSCLE WEAKNESS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; SINUS RHYTHM; SPHINCTER; STOMACH MUCOSA; T WAVE; TREATMENT RESPONSE;

ACTION POTENTIALS; ADMINISTRATION, ORAL; ANIMALS; ANTI-ULCER AGENTS; ARGININE; ARRHYTHMIAS, CARDIAC; BLOOD PRESSURE; ELECTROLYTES; HEART; HEART RATE; HEK293 CELLS; HUMANS; HYPERKALEMIA; INJECTIONS, INTRAPERITONEAL; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; POTASSIUM CHLORIDE; PROTEINS; RATS; RATS, WISTAR; STOMACH; SURVIVAL ANALYSIS;

EID: 84874005842     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.12.007     Document Type: Article

References (43)

1. Borok Z., Schneider S.M., Fraley D.S., Adler S. A rat model for hyperkalemia. Proc Soc Exp Biol Med 1987, 185:39-40.
2. Sikiric P., Seiwerth S., Brcic L., Sever M., Klicek R., Radic B., Drmic D., Ilic S., Kolenc D. Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator. Curr Pharm Des 2010, 16:1224-1234.
3. Sikiric P., Seiwerth S., Rucman R., Turkovic B., Rokotov D.S., Brcic L., Sever M., Klicek R., Radic B., Drmic D., Ilic S., Kolenc D., Vrcic H., Sebecic B. Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract. Curr Pharm Des 2011, 17:1612-1632.
4. Sikiric P., Seiwerth S., Rucman R., Turkovic B., Rokotov D.S., Brcic L., Sever M., Klicek R., Radic B., Drmic D., Ilic S., Kolenc D., Stambolija V., Zoricic Z., Vrcic H., Sebecic B. Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157. Curr Med Chem 2012, 19:126-132.
5. Sikiric P., Seiwerth S., Rucman R., Turkovic B., Stancic Rokotov D.S., Brcic L., Sever M., Klicek R., Radic B., Drmic D., Ilic S., Kolenc D., Aralica G., Safic H., Suran J., Rak D., Dzidic S., Vrcic H., Sebecic B. Toxicity by NSAIDs, Counteraction by stable gastric pentadecapeptide BPC 157. Curr Pharm Des 2013, 19:76-83.
6. Balenovic D., Bencic M.L., Udovicic M., Simonji K., Hanzevacki J.S., Barisic I., Kranjcevic S., Prkacin I., Coric V., Brcic L., Coric M., Brcic I., Borovic S., Radic B., Drmic D., Vrcic H., Seiwerth S., Sikiric P. Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: a relation with NO-system. Regul Pept 2009, 156:83-89.
7. Bencic M.L., Sikiric P., Hanzevacki J.S., Seiwerth S., Rogic D., Kusec V., Aralica G., Konjevoda P., Batelja L., Blagaić A.B. Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse. J Pharmacol Sci 2004, 95:19-26.
8. Klicek R., Sever M., Radic B., Drmic D., Kocman I., Zoricic I., Vuksic T., Ivica M., Barisic I., Ilic S., Berkopic L., Vrcic H., Brcic L., Blagaic A.B., Coric M., Brcic I., Rokotov D.S., Anic T., Seiwerth S., Sikiric P. Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system. J Pharmacol Sci 2008, 108:7-17.
9. Boban-Blagaic A., Blagaic V., Romic Z., Jelovac N., Dodig G., Rucman R., Petek M., Turkovic B., Seiwerth S., Sikiric P. The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. The effect of N(G)-nitro-l-arginine methyl ester and l-arginine. Med Sci Monit 2006, 12:BR36-BR45.
10. Sikirić P., Seiwerth S., Grabarević Z., Rucman R., Petek M., Jagić V., Turković B., Rotkvić I., Mise S., Zoricić I., Konjevoda P., Perović D., Jurina L., Separović J., Hanzevacki M., Artuković B., Bratulić M., Tisljar M., Gjurasin M., Miklić P., et al. The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-l-arginine methylester and l-arginine effects on stomach mucosa integrity and blood pressure. Eur J Pharmacol 1997, 332:23-33.
11. Grabarevic Z., Tisljar M., Artukovic B., Bratulic M., Dzaja P., Seiwerth S., Sikiric P., Peric J., Geres D., Kos J. The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks. J Physiol Paris 1997, 91:139-149.
12. Bosnjak Z.J., Graf B.M., Sikiric P., Stowe D.F. Protective effects of newly isolated gastric peptide following hypoxic and reoxygenation injury in the isolated guinea pig heart. FASEB J 1994, 8:12.
13. Clausen T. Hormonal and pharmacological modification of plasma potassium homeostasis. Fundam Clin Pharmacol 2010, 24:595-605.
14. Hack J.B., Woody J.H., Lewis D.E., Brewer K., Meggs W.J. The effect of calcium chloride in treating hyperkalemia due to acute digoxin toxicity in a porcine model. J Toxicol Clin Toxicol 2004, 42:337-342.
15. Dobric I., Drvis P., Petrovic I., Shejbal D., Brcic L., Blagaic A.B., Batelja L., Sever M., Kokic N., Tonkic A., Zoricic I., Mise S., Staresinic M., Radic B., Jakir A., Babel J., Ilic S., Vuksic T., Jelic I., Anic T., et al. Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157. J Pharmacol Sci 2007, 104:7-18.
16. Petrovic I., Dobric I., Drvis P., Shejbal D., Brcic L., Blagaic A.B., Batelja L., Kokic N., Tonkic A., Mise S., Baotic T., Staresinic M., Radic B., Jakir A., Vuksic T., Anic T., Seiwerth S., Sikiric P. An experimental model of prolonged esophagitis with sphincter failure in the rat and the therapeutic potential of gastric pentadecapeptide BPC 157. J Pharmacol Sci 2006, 102:269-277.
17. Petrovic I., Dobric I., Drmic D., Sever M., Klicek R., Radic B., Brcic L., Kolenc D., Zlatar M., Kunjko K., Juricic D., Martinac M., Rasic M., Boban-Blagaic A., Romic Z., Seiwerth S., Sikiric P. BPC 157 therapy to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis patients low sphincters pressure. J Physiol Pharmacol 2011, 62:527-534.
18. Staresinic M., Petrovic I., Novinscak T., Jukic I., Pevec D., Suknaic S., Kokic N., Batelja L., Brcic L., Boban-Blagaic A., Zoric Z., Ivanovic D., Ajduk M., Sebecic B., Patrlj L., Sosa T., Buljat G., Anic T., Seiwerth S., Sikiric P. Effective therapy of transected quadriceps muscle in rat: gastric pentadecapeptide BPC 157. J Orthop Res 2006, 24:1109-1117.
19. Pevec D., Novinscak T., Brcic L., Sipos K., Jukic I., Staresinic M., Mise S., Brcic I., Kolenc D., Klicek R., Banic T., Sever M., Kocijan A., Berkopic L., Radic B., Buljat G., Anic T., Zoricic I., Bojanic I., Seiwerth S., et al. Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application. Med Sci Monit 2010, 16:BR81-BR88.
20. Novinscak T., Brcic L., Staresinic M., Jukic I., Radic B., Pevec D., Mise S., Tomasovic S., Brcic I., Banic T., Jakir A., Buljat G., Anic T., Zoricic I., Romic Z., Seiwerth S., Sikiric P. Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat. Surg Today 2008, 38:716-725.
21. Tudor M., Jandric I., Marovic A., Gjurasin M., Perovic D., Radic B., Blagaic A.B., Kolenc D., Brcic L., Zarkovic K., Seiwerth S., Sikiric P. Traumatic brain injury in mice and pentadecapeptide BPC 157 effect. Regul Pept 2010, 160:26-32.
22. Gjurasin M., Miklic P., Zupancic B., Perovic D., Zarkovic K., Brcic L., Kolenc D., Radic B., Seiwerth S., Sikiric P. Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury. Regul Pept 2010, 160:33-41.
23. Sherman A., Bini E.J. Pill-induced gastric injury. Am J Gastroenterol 1999, 94:511-513.
24. Todorović Z., Prostran M.S., Varagić V., Zunić G., Savić J., Vujnov S. The cardiovascular effects of the administration of L-NAME during the early posthemorrhagic period. Gen Pharmacol 1998, 30:763-769.
25. Mellander S., Björnberg J., Ekelund U., Alm P. Cardiovascular regulation by endogenous nitric oxide is essential for survival after acute haemorrhage. Acta Physiol Scand 1997, 160:57-65.
26. 2+) channels in the local abnormalities and hyperkalemia following the ischemia-reperfusion injury of rat skeletal muscle. Neuromuscul Disord 2002, 12:258-265.
27. Fujiwara N., Osanai T., Kamada T., Katoh T., Takahashi K., Okumura K. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt intake. Circulation 2000, 101:856-861.
28. Hiatt N., Katayanagi T., Miller A. Cardiac sensitivity to hyperkalemia in adrenalectomized dogs. Proc Soc Exp Biol Med 1975, 149:168-171.
29. Hollmann M.W., Strümper D., Salmons V.A., Washington J.M., Durieux M.E. Effects of calcium and magnesium pretreatment on hyperkalaemic cardiac arrest in rats. Eur J Anaesthesiol 2003, 20:606-611.
30. Greger R., Kunzelmann K. Simultaneous recording of the cell membrane potential and properties of the cell attached membrane of HT29 colon carcinoma and CF-PAC cells. Pflugers Arch 1991, 419:209-211.
31. Pabla R., Curtis M.J. Effects of NO modulation on cardiac arrhythmias in the rat isolated Heart. Circ Res 1995, 77:984-992.
32. Gazitua R., Wilson K., Bistrian B.N., Blackbum G.L. Factors determining peripheral vein tolerance to amino acid infusions. Arch Surg 1979, 114:897-900.
33. Bassenge E., Busse R. Endothelial modulation of coronary tone. Prog Cardiovasc Dis 1988, 30:349-380.
34. Vanhoutte I.M., Houston D.S. Platelets, endothelium and vasospasm. Circulation 1985, 72:728-734.
35. Bertol E., Politi L., Mari F. Death by potassium chloride intravenous injection: evaluation of analytical detectability. J Forensic Sci 2012, 57:273-275.
36. Khuri R.N., Agulian S.K., Abdulnour-Nakhoul S., Nakhoul N.L. Electrochemical potentials of potassium in skeletal muscle under different metabolic states. J Cell Physiol 1992, 153:534-538.
37. + channel inactivation by anemone toxin (ATX II) mimics the myotonic state in hyperkalaemic periodic paralysis. J Physiol 1993, 466:501-520.
38. John S.K., Rangan Y., Block C.A., Koff M.D. Life-threatening hyperkalemia from nutritional supplements: uncommon or undiagnosed?. Am J Emerg Med 2011, 29:1237.e1-1237.e2.
39. Bilic M., Bumber Z., Blagaic A.B., Batelja L., Seiwerth S., Sikiric P. The stable gastric pentadecapeptide BPC 157, given locally, improves CO2 laser healing in mice. Burns 2003, 31:310-315.
40. Mikus D., Sikiric P., Seiwerth S., Petricevic A., Aralica G., Druzijancic N., Rucman R., Patek M., Pigac B., Perovic D., Kolombo M., Kokic N., Mikus S., Duplancic B., Fattorini I., Turkovic B., Rotkvic I., Mise S., Prkacin I., Konjevoda P., et al. Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice. Burns 2001, 27:817-827.
41. Sikiric P., Seiwerth S., Mise S., Staresinic M., Bedekovic V., Zarkovic N., Borovic S., Gjurasin M., Boban-Blagaic A., Batelja L., Rucman R., Anic T. Corticosteroid-impairment of healing and gastric pentadecapeptide BPC 157 creams in burned mice. Burns 2003, 29:323-334.
42. Stupnisek M., Franjic S., Drmic D., Hrelec M., Kolenc D., Radic B., Bojic D., Vcev A., Seiwerth S., Sikiric P. Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin. Thromb Res 2011, 129:652-659.
43. Hirsch J., Schlatter E. Genistein potentiates the ANP effect on a K(+)-conductance in HEK293 cells. Cell Physiol Biochem 2003, 13:223-228.